US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 0.452
  • -0.011-2.46%
Close Nov 27 16:00 ET
  • 0.460
  • +0.008+1.68%
Post 20:01 ET
21.87MMarket Cap-221P/E (TTM)

BioXcel Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-37.24%214K
141.58%1.1M
182.52%582K
268.00%1.38M
57.98%376K
148.91%341K
457K
206K
375K
238K
Operating revenue
-37.24%214K
141.58%1.1M
182.52%582K
268.00%1.38M
57.98%376K
148.91%341K
--457K
--206K
--375K
--238K
Cost of revenue
128.52%1.17M
138.46%62K
788.89%80K
6,200.00%1.26M
7,833.33%714K
4,554.55%512K
26K
9K
20K
9K
Gross profit
-459.06%-956K
141.76%1.04M
154.82%502K
-66.20%120K
-247.60%-338K
-235.71%-171K
431K
197K
355K
229K
Operating expense
-70.92%12.78M
-66.92%17.48M
-52.01%24.67M
4.84%167.74M
-63.22%19.54M
12.39%43.96M
45.63%52.85M
63.26%51.4M
49.62%160M
103.29%53.12M
Selling and administrative expenses
-68.44%7.68M
-63.47%9.45M
-43.78%13.26M
21.31%83.41M
-53.53%9.6M
42.75%24.34M
40.75%25.87M
82.61%23.6M
26.80%68.76M
51.86%20.66M
-Selling and marketing expense
-76.92%1.06M
-95.59%305K
-66.44%872K
6.93%19.9M
-85.26%1.43M
67.90%4.6M
9.46%6.91M
281.50%2.6M
520.09%18.61M
600.65%9.67M
-General and administrative expense
-66.47%6.62M
-51.77%9.15M
-40.98%12.39M
26.64%63.51M
-25.62%8.18M
37.94%19.75M
57.11%18.96M
71.54%21M
-2.10%50.15M
-10.08%11M
Research and development costs
-74.00%5.1M
-70.22%8.03M
-58.99%11.4M
-7.58%84.33M
-69.40%9.93M
-11.07%19.62M
50.64%26.97M
49.79%27.8M
73.10%91.24M
159.15%32.46M
Operating profit
68.87%-13.74M
68.63%-16.44M
52.80%-24.16M
-4.99%-167.62M
62.42%-19.88M
-13.19%-44.13M
-44.44%-52.41M
-62.64%-51.2M
-49.29%-159.65M
-102.41%-52.89M
Net non-operating interest income expense
-45.33%-3.17M
-84.92%-3.03M
-96.75%-2.66M
-34.83%-7.67M
-73.57%-2.49M
24.09%-2.18M
-18.52%-1.64M
-17,000.00%-1.35M
-142,225.00%-5.69M
-24,000.00%-1.43M
Non-operating interest income
-42.32%616K
-58.61%671K
-53.00%947K
123.46%5.65M
-36.34%946K
29.77%1.07M
694.61%1.62M
13,333.33%2.02M
5,645.45%2.53M
--1.49M
Non-operating interest expense
16.54%3.79M
13.53%3.7M
7.13%3.61M
62.11%13.31M
17.64%3.44M
-12.11%3.25M
105.49%3.26M
48,000.00%3.37M
20,432.50%8.21M
--2.92M
Other net income (expense)
178.31%3.26M
1,980.07%11.17M
113.01%32K
-782.67%-3.77M
122.50%108K
-6,822.58%-4.17M
537K
-246K
-427K
-480K
Special income (charges)
62.70%-1.55M
---856K
----
---4.16M
--0
---4.16M
--0
----
--0
--0
-Less:Restructuring and merger&acquisition
-62.70%1.55M
--856K
----
--4.16M
--0
--4.16M
--0
----
--0
--0
Other non- operating income (expenses)
96,440.00%4.82M
2,139.48%12.03M
113.01%32K
192.27%394K
122.50%108K
-108.06%-5K
--537K
---246K
---427K
---480K
Income before tax
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.78%-54.81M
Income tax
Net income
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.78%-54.81M
Net income continuous Operations
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.78%-54.81M
Minority interest income
Net income attributable to the parent company
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.79%-54.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
72.96%-13.65M
84.49%-8.3M
49.26%-26.79M
-8.02%-179.05M
59.39%-22.26M
-20.77%-50.49M
-42.06%-53.52M
-67.76%-52.8M
-55.01%-165.76M
-109.79%-54.81M
Basic earnings per share
81.40%-0.32
88.52%-0.21
52.72%-0.87
-3.89%-6.15
61.03%-0.76
-15.44%-1.72
-35.56%-1.83
-64.29%-1.84
-46.17%-5.92
-109.68%-1.95
Diluted earnings per share
81.40%-0.32
88.52%-0.21
52.72%-0.87
-3.89%-6.15
61.03%-0.76
-15.44%-1.72
-35.56%-1.83
-64.29%-1.84
-46.17%-5.92
-109.68%-1.95
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -37.24%214K141.58%1.1M182.52%582K268.00%1.38M57.98%376K148.91%341K457K206K375K238K
Operating revenue -37.24%214K141.58%1.1M182.52%582K268.00%1.38M57.98%376K148.91%341K--457K--206K--375K--238K
Cost of revenue 128.52%1.17M138.46%62K788.89%80K6,200.00%1.26M7,833.33%714K4,554.55%512K26K9K20K9K
Gross profit -459.06%-956K141.76%1.04M154.82%502K-66.20%120K-247.60%-338K-235.71%-171K431K197K355K229K
Operating expense -70.92%12.78M-66.92%17.48M-52.01%24.67M4.84%167.74M-63.22%19.54M12.39%43.96M45.63%52.85M63.26%51.4M49.62%160M103.29%53.12M
Selling and administrative expenses -68.44%7.68M-63.47%9.45M-43.78%13.26M21.31%83.41M-53.53%9.6M42.75%24.34M40.75%25.87M82.61%23.6M26.80%68.76M51.86%20.66M
-Selling and marketing expense -76.92%1.06M-95.59%305K-66.44%872K6.93%19.9M-85.26%1.43M67.90%4.6M9.46%6.91M281.50%2.6M520.09%18.61M600.65%9.67M
-General and administrative expense -66.47%6.62M-51.77%9.15M-40.98%12.39M26.64%63.51M-25.62%8.18M37.94%19.75M57.11%18.96M71.54%21M-2.10%50.15M-10.08%11M
Research and development costs -74.00%5.1M-70.22%8.03M-58.99%11.4M-7.58%84.33M-69.40%9.93M-11.07%19.62M50.64%26.97M49.79%27.8M73.10%91.24M159.15%32.46M
Operating profit 68.87%-13.74M68.63%-16.44M52.80%-24.16M-4.99%-167.62M62.42%-19.88M-13.19%-44.13M-44.44%-52.41M-62.64%-51.2M-49.29%-159.65M-102.41%-52.89M
Net non-operating interest income expense -45.33%-3.17M-84.92%-3.03M-96.75%-2.66M-34.83%-7.67M-73.57%-2.49M24.09%-2.18M-18.52%-1.64M-17,000.00%-1.35M-142,225.00%-5.69M-24,000.00%-1.43M
Non-operating interest income -42.32%616K-58.61%671K-53.00%947K123.46%5.65M-36.34%946K29.77%1.07M694.61%1.62M13,333.33%2.02M5,645.45%2.53M--1.49M
Non-operating interest expense 16.54%3.79M13.53%3.7M7.13%3.61M62.11%13.31M17.64%3.44M-12.11%3.25M105.49%3.26M48,000.00%3.37M20,432.50%8.21M--2.92M
Other net income (expense) 178.31%3.26M1,980.07%11.17M113.01%32K-782.67%-3.77M122.50%108K-6,822.58%-4.17M537K-246K-427K-480K
Special income (charges) 62.70%-1.55M---856K-------4.16M--0---4.16M--0------0--0
-Less:Restructuring and merger&acquisition -62.70%1.55M--856K------4.16M--0--4.16M--0------0--0
Other non- operating income (expenses) 96,440.00%4.82M2,139.48%12.03M113.01%32K192.27%394K122.50%108K-108.06%-5K--537K---246K---427K---480K
Income before tax 72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.78%-54.81M
Income tax
Net income 72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.78%-54.81M
Net income continuous Operations 72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.78%-54.81M
Minority interest income
Net income attributable to the parent company 72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.79%-54.81M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 72.96%-13.65M84.49%-8.3M49.26%-26.79M-8.02%-179.05M59.39%-22.26M-20.77%-50.49M-42.06%-53.52M-67.76%-52.8M-55.01%-165.76M-109.79%-54.81M
Basic earnings per share 81.40%-0.3288.52%-0.2152.72%-0.87-3.89%-6.1561.03%-0.76-15.44%-1.72-35.56%-1.83-64.29%-1.84-46.17%-5.92-109.68%-1.95
Diluted earnings per share 81.40%-0.3288.52%-0.2152.72%-0.87-3.89%-6.1561.03%-0.76-15.44%-1.72-35.56%-1.83-64.29%-1.84-46.17%-5.92-109.68%-1.95
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data